PDUFA VIII negotiations offer a chance to align the FDA's user fee program with the Trump Administration's focus on efficiency, lobbyists said. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
